K-562 is derived from a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. It was the first human immortalised myelogenous leukemia line to be established.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
Human Leukemia Cell Lines
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.